Kim S Bull1, Samantha Hornsey2, Colin R Kennedy1, Anne-Sophie E Darlington3, Martha A Grootenhuis4, Darren Hargrave5,6, Christina Liossi7,8, Jonathan P Shepherd9, David A Walker10, Christopher Morris11. 1. Clinical and Experimental Sciences, University of Southampton, UK. 2. Primary Care, Population Sciences, and Medical Education, University of Southampton, UK. 3. Health Sciences, University of Southampton, UK. 4. Psychosocial Research and Healthcare Innovation, Princess Máxima Centre for Paediatric Oncology, Utrecht, NL. 5. UCL Great Ormond Street Institute of Child Health, University College London, UK. 6. Paediatric Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London,UK. 7. Psychology, University of Southampton, UK. 8. Pain Control Service, Great Ormond Street Hospital for Children NHS Trust, UK. 9. Southampton Health Technology Assessments Centre, University of Southampton, UK. 10. Children's Brain Tumour Research Centre, University of Nottingham, UK. 11. The Peninsula Childhood Disability Research Unit, University of Exeter, UK.
Abstract
BACKGROUND: Survivors of childhood brain tumors or other acquired brain injury (ABI) are at risk of poor health-related quality of life (HRQoL); its valid and reliable assessment is essential to evaluate the effect of their illness on their lives. The aim of this review was to critically appraise psychometric properties of patient-reported outcome measures (PROMs) of HRQoL for these children, to be able to make informed decisions about the most suitable PROM for use in clinical practice. METHODS: We searched MEDLINE, EMBASE, and PsycINFO for studies evaluating measurement properties of HRQoL PROMs in children treated for brain tumors or other ABI. Methodological quality of relevant studies was evaluated using the consensus-based standards for the selection of health status measurement instruments checklist. RESULTS: Eight papers reported measurement properties of 4 questionnaires: Health Utilities Index (HUI), PedsQL Core and Brain Tumor Modules, and Child and Family Follow-up Survey (CFFS). Only the CFFS had evidence of content and structural validity. It also demonstrated good internal consistency, whereas both PedsQL modules had conflicting evidence regarding this. Conflicting evidence regarding test-retest reliability was reported for the HUI and PedsQL Core Module only. Evidence of measurement error/precision was favorable for HUI and CFFS and absent for both PedsQL modules. All 4 PROMs had some evidence of construct validity/hypothesis testing but no evidence of responsiveness to change. CONCLUSIONS: Valid and reliable assessment is essential to evaluate impact of ABI on young lives. However, measurement properties of PROMs evaluating HRQoL appropriate for this population require further evaluation, specifically construct validity, internal consistency, and responsiveness to change.
BACKGROUND: Survivors of childhood brain tumors or other acquired brain injury (ABI) are at risk of poor health-related quality of life (HRQoL); its valid and reliable assessment is essential to evaluate the effect of their illness on their lives. The aim of this review was to critically appraise psychometric properties of patient-reported outcome measures (PROMs) of HRQoL for these children, to be able to make informed decisions about the most suitable PROM for use in clinical practice. METHODS: We searched MEDLINE, EMBASE, and PsycINFO for studies evaluating measurement properties of HRQoL PROMs in children treated for brain tumors or other ABI. Methodological quality of relevant studies was evaluated using the consensus-based standards for the selection of health status measurement instruments checklist. RESULTS: Eight papers reported measurement properties of 4 questionnaires: Health Utilities Index (HUI), PedsQL Core and Brain Tumor Modules, and Child and Family Follow-up Survey (CFFS). Only the CFFS had evidence of content and structural validity. It also demonstrated good internal consistency, whereas both PedsQL modules had conflicting evidence regarding this. Conflicting evidence regarding test-retest reliability was reported for the HUI and PedsQL Core Module only. Evidence of measurement error/precision was favorable for HUI and CFFS and absent for both PedsQL modules. All 4 PROMs had some evidence of construct validity/hypothesis testing but no evidence of responsiveness to change. CONCLUSIONS: Valid and reliable assessment is essential to evaluate impact of ABI on young lives. However, measurement properties of PROMs evaluating HRQoL appropriate for this population require further evaluation, specifically construct validity, internal consistency, and responsiveness to change.
Authors: Lidwine B Mokkink; Caroline B Terwee; Donald L Patrick; Jordi Alonso; Paul W Stratford; Dirk L Knol; Lex M Bouter; Henrica C W de Vet Journal: J Clin Epidemiol Date: 2010-07 Impact factor: 6.437
Authors: Stephanie N Palmer; Kathleen A Meeske; Ernest R Katz; Tasha M Burwinkle; James W Varni Journal: Pediatr Blood Cancer Date: 2007-09 Impact factor: 3.167
Authors: Astrid Janssens; Morwenna Rogers; Jo Thompson Coon; Karen Allen; Colin Green; Crispin Jenkinson; Alan Tennant; Stuart Logan; Christopher Morris Journal: Value Health Date: 2015-03 Impact factor: 5.725
Authors: Galina Velikova; Laura Booth; Adam B Smith; Paul M Brown; Pamela Lynch; Julia M Brown; Peter J Selby Journal: J Clin Oncol Date: 2004-02-15 Impact factor: 44.544
Authors: Astrid Janssens; Morwenna Rogers; Rebecca Gumm; Crispin Jenkinson; Alan Tennant; Stuart Logan; Christopher Morris Journal: Dev Med Child Neurol Date: 2015-12-11 Impact factor: 5.449